- Home
- SRM vs ATHE Comparison
SRM vs ATHE Comparison
Compare SRM & ATHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRM
- ATHE
- Stock Information
- Founded
- SRM 1979
- ATHE 1997
- Country
- SRM United States
- ATHE Australia
- Employees
- SRM N/A
- ATHE N/A
- Industry
- SRM
- ATHE Biotechnology: Pharmaceutical Preparations
- Sector
- SRM
- ATHE Health Care
- Exchange
- SRM Nasdaq
- ATHE Nasdaq
- Market Cap
- SRM 11.7M
- ATHE 10.1M
- IPO Year
- SRM 2023
- ATHE N/A
- Fundamental
- Price
- SRM $0.62
- ATHE $2.16
- Analyst Decision
- SRM
- ATHE Strong Buy
- Analyst Count
- SRM 0
- ATHE 2
- Target Price
- SRM N/A
- ATHE $6.00
- AVG Volume (30 Days)
- SRM 8.0M
- ATHE 118.8K
- Earning Date
- SRM 11-13-2024
- ATHE 12-24-2024
- Dividend Yield
- SRM N/A
- ATHE N/A
- EPS Growth
- SRM N/A
- ATHE N/A
- EPS
- SRM N/A
- ATHE N/A
- Revenue
- SRM $4,594,304.00
- ATHE $2,681,669.00
- Revenue This Year
- SRM N/A
- ATHE N/A
- Revenue Next Year
- SRM N/A
- ATHE N/A
- P/E Ratio
- SRM N/A
- ATHE N/A
- Revenue Growth
- SRM N/A
- ATHE 2.63
- 52 Week Low
- SRM $0.55
- ATHE $1.00
- 52 Week High
- SRM $3.05
- ATHE $3.19
- Technical
- Relative Strength Index (RSI)
- SRM 46.02
- ATHE 64.93
- Support Level
- SRM $0.70
- ATHE $2.18
- Resistance Level
- SRM $0.88
- ATHE $2.45
- Average True Range (ATR)
- SRM 0.11
- ATHE 0.25
- MACD
- SRM -0.01
- ATHE 0.03
- Stochastic Oscillator
- SRM 3.91
- ATHE 74.63
About SRM SRM Entertainment Inc.
SRM Entertainment Inc is a trusted toy and souvenir designer and developer, selling into theme parks and entertainment venues. It has developed, manufactured, and supplied the entertainment and amusement park industry with exclusive products that are often only available to consumers inside SRM's customer base venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Six Flags, Great Wolf Lodge, Dollywood, and Merlin Entertainment. Its product category includes The Smurfs and Zoonicorns, Sammy Sloth, lilita Llama, kyle Koala, and Hanna Hedgehog.
About ATHE Alterity Therapeutics Limited
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.